Raben David
SEC CIK 2034679 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Chief Medical Off | 60.8K | — | $1.15M | 11 | 2025-10-09 | 2026-04-27 |
Most active insiders at BCAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $4.80M | — |
| 2 | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | — | $4.60M |
| 3 | Mazumdar Claire | CEO, Dir | — | $4.06M |
| 4 | Hyep Ivan | CFO | — | $3.24M |
| 5 | Raben David | Chief Medical Off | — | $1.15M |
| 6 | Meisner Lara | CLO | — | $498.7K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-28 19:49 | 2026-04-27 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | M - OptEx | $3.79 | +5,500 | 60.8K | +10% | +$20.8K |
| DT | 2026-04-28 19:49 | 2026-04-27 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | S - Sale+OE | $22.88 | -5,500 | 55.3K | -9% | -$125.8K |
| D | 2026-03-26 | 2026-03-25 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | S - Sale+OE | $18.95 | -5,500 | 55.3K | -9% | -$104.2K |
| D | 2026-03-26 | 2026-03-25 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | M - OptEx | $3.79 | +5,500 | 60.8K | +10% | +$20.8K |
| DM | 2026-03-05 | 2026-03-03+ | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | S - Sale+OE | $18.52 | -16.5K | 55.3K | -23% | -$305.6K |
| DM | 2026-03-05 | 2026-03-03+ | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | M - OptEx | $3.79 | +16.5K | 55.5K | +42% | +$62.5K |
| D | 2025-12-29 | 2025-12-26 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | M - OptEx | $3.79 | +19.8K | 55.3K | +56% | +$75.0K |
| DM | 2025-11-25 | 2025-11-24+ | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | M - OptEx | $3.79 | +11.0K | 40.1K | +38% | +$41.7K |
| DM | 2025-11-25 | 2025-11-24+ | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | S - Sale+OE | $18.64 | -11.0K | 35.5K | -24% | -$205.1K |
| D | 2025-10-10 | 2025-10-09 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | M - OptEx | $3.79 | +22.0K | 57.5K | +62% | +$83.4K |
| D | 2025-10-10 | 2025-10-09 | BCAX | Bicara Therapeutics Inc. | Raben David | Chief Medical Off | S - Sale+OE | $18.45 | -22.0K | 35.5K | -38% | -$405.9K |
Purchase Sale Sale after option exercise All abbreviations